UBS lowered the firm’s price target on Aramark (ARMK) to $45 from $46 and keeps a Buy rating on the shares. UBS sees a “tricky” setup for Aramark with several moving parts on growth and margins heading into the Q4 print, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARMK:
- Positive Growth Outlook for ARAMARK Holdings Despite Revenue Challenges
- Aramark Holdings Refinances Loans with New Agreement
- Soros boosts exits stake in AstraZeneca, cuts position in Alphabet
- ARAMARK Holdings: Strong Growth Prospects and Strategic Investments Justify Buy Rating
- Aramark price target raised to $46 from $44 at UBS